Ramtin Agah - Apr 8, 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin Agah
Stock symbol
RNXT
Transactions as of
Apr 8, 2025
Transactions value $
$21,840
Form type
4
Date filed
4/9/2025, 12:45 PM
Previous filing
Jan 30, 2024
Next filing
Apr 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNXT Common Stock Purchase $21.8K +26K +2.54% $0.84 1.05M Apr 8, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects open market purchases of the Issuer's securities.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.825 to $0.8499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3 Includes 975,000 shares, which are held of record by the reporting person currently and were held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016 and reported as indirectly held by the reporting person previously.